600 patients66,869 observations120 daysLIVE

Patient P-01697

Synthetic patientNBL-101 · Day 119 · 25–34 · M · baseline S09Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
73%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S09
  2. Day 84 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 84.

Primary contributors, last 14 days
  • GI instability+8
  • Inflammatory activity-8
  • Toxicity-5

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    61%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 83% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    67.3/100
    worsening · +12.1 vs previous 14 d
    Toxicity
    Blood
    52.3/100
    worsening · +3.7 vs previous 14 d
    Sleep quality
    Wearable
    27.1/100
    worsening · -3.7 vs previous 14 d
    Energy level
    Daily log
    3/10
    worsening · -0.6 vs previous 14 d
    Stress level
    Daily log
    6.9/10
    worsening · +0.5 vs previous 14 d
    Steps
    Wearable
    456
    worsening · -843 vs previous 14 d
    Adherence
    Companion
    61.2 %
    worsening · -8.3 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 32 from the failing basin, 68 from restoration.

    Would help
    • GI-04 GI Support Protocol
      73% improved among 124 similar · onset 8 d · confidence 59%
    • ME-01 Monitoring Escalation
      100% improved among 77 similar · onset 3 d · confidence 66%
    • NP-02 Dietary Support Protocol
      63% improved among 64 similar · onset 10 d · confidence 66%
    Would not help
    • Keep fat low
      GI +3.8 next day on high-intake days · n 20
    • Keep alcohol low
      GI +3.8 next day on high-intake days · n 18
    • Keep spicy low
      GI +2.4 next day on high-intake days · n 22
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Dietary fat load
      +3.8detractor · 95%
    • Alcohol
      +3.8detractor · 95%
    • Spicy / capsaicin
      +2.4detractor · 94%
    • Simple carbohydrates
      +1.9detractor · 66%
    • Insoluble fibre
      -1.5no signal · 43%
    • Histamine load
      +0.9no signal · 30%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 80
      • MicrobiomeButyrate capacity 26/100
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Autonomic recovery 65
      • WearableResting HR 84 bpm
      • Wearable456 steps/day
      • WearableShort sleep window
    • Mucosal barrier integrity 60
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 67 and rising
      • WearableSleep 6.1 h, below personal baseline
    • Inflammatory signalling 50
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • BloodInflammatory load index 63
    • Drug metabolism and exposure 20
      • BloodToxicity index 52
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.1 · butyrate capacity 26/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    40 ms
    Sleep
    6.3 h
    Steps
    1,088
    Resting HR
    85 bpm
    Daily log: GI score 67, nutritional resilience 32, adherence 61.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0189621%S0775
    P-0181921%S1372
    P-0160421%S0171
    P-0138621%S1370
    P-0135222%S2070
    P-0175022%S1669
    P-0169936%S04GI-04improved69
    P-0150821%S1868
    P-0175421%S1468
    P-0150923%S1768
    P-0187521%S1167
    P-0181721%S1467